Companies

AstraZeneca has won an interlocutory injunction barring Pharmacor from making a generic version of its blockbuster diabetes drug Forxiga while a patent case over the drug proceeds.

Coles changed its marketing policies after being concerned it could not compete with Woolworths, a court has heard on the first day of trial in the consumer regulator’s case over the supermarket's “utterly misleading” discounts.

Qube's board has accepted an $11.7 billion takeover offer by a Macquarie Asset Management-led consortium, saying the deal represents a "significant premium" on the infrastructure giant's share price.

Qantas has brought a strike-out application in a class action on behalf of hundreds of thousands of customers who allegedly never received refunds after their flights were cancelled during the COVID-19 pandemic. 

Telstra has lost its bid for a split trial in a case looking to put the telco on the hook for an ex-employee's alleged sexual harassment of his neighbours.

Cbus has reportedly agreed to acquire all the units in Lendlease's $2 billion shopping centre fund, which includes some of the country's largest mall assets.

Dexus’ industrial real estate trust has bought a half-stake in an industrial estate in NSW for $49.6 million from its manager. 

The federal government will try to exclude women who served in the army from a landmark class action over alleged systemic sexual violence, harassment and discrimination in the Australian Defence Force. 

Kmart is fighting a discovery bid by a representative body for members of the Uyghur ethnic minority, saying there is “no reasonable basis” for believing it misled the public about alleged modern slavery risks in its supply chain.

The defendants in Lendlease's lawsuit over combustible cladding used on its $107 million EXO residential apartment block in Melbourne's Docklands have pointed the finger at one another six months out from trial in the long-running proceedings.